全文获取类型
收费全文 | 33369篇 |
免费 | 1879篇 |
国内免费 | 175篇 |
专业分类
耳鼻咽喉 | 438篇 |
儿科学 | 707篇 |
妇产科学 | 740篇 |
基础医学 | 4242篇 |
口腔科学 | 1678篇 |
临床医学 | 2457篇 |
内科学 | 8623篇 |
皮肤病学 | 848篇 |
神经病学 | 2616篇 |
特种医学 | 656篇 |
外科学 | 5510篇 |
综合类 | 227篇 |
一般理论 | 4篇 |
预防医学 | 2307篇 |
眼科学 | 607篇 |
药学 | 1880篇 |
中国医学 | 139篇 |
肿瘤学 | 1744篇 |
出版年
2023年 | 254篇 |
2022年 | 204篇 |
2021年 | 1143篇 |
2020年 | 632篇 |
2019年 | 1214篇 |
2018年 | 1376篇 |
2017年 | 806篇 |
2016年 | 845篇 |
2015年 | 1032篇 |
2014年 | 1508篇 |
2013年 | 1808篇 |
2012年 | 2883篇 |
2011年 | 2946篇 |
2010年 | 1691篇 |
2009年 | 1458篇 |
2008年 | 2252篇 |
2007年 | 2317篇 |
2006年 | 2097篇 |
2005年 | 1854篇 |
2004年 | 1731篇 |
2003年 | 1566篇 |
2002年 | 1446篇 |
2001年 | 212篇 |
2000年 | 185篇 |
1999年 | 215篇 |
1998年 | 172篇 |
1997年 | 152篇 |
1996年 | 118篇 |
1995年 | 139篇 |
1994年 | 107篇 |
1993年 | 98篇 |
1992年 | 88篇 |
1991年 | 72篇 |
1990年 | 74篇 |
1989年 | 54篇 |
1988年 | 56篇 |
1987年 | 46篇 |
1986年 | 36篇 |
1985年 | 47篇 |
1984年 | 40篇 |
1983年 | 43篇 |
1982年 | 50篇 |
1981年 | 45篇 |
1980年 | 42篇 |
1979年 | 21篇 |
1978年 | 25篇 |
1977年 | 27篇 |
1976年 | 20篇 |
1975年 | 27篇 |
1974年 | 23篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
91.
Andrea Briones-Figueroa Walter Alberto Sifuentes-Giraldo José Luis Morell-Hita Mónica Vázquez-Díaz 《Reumatología clinica》2021,17(3):141-143
BackgroundFluoroquinolones have been associated with increased risk of tendinopathy and Achilles tendon rupture (ATR), especially in patients over 60 years of age.MethodsA retrospective study was carried out including patients over 60 years of age with ATR attended in our centre over the period 2000-2017.ResultsWe identified 44 patients with RTA, of whom 18% (8/44) had been previously treated with fluoroquinolones, with a mean age at diagnosis of ATR of 77.37 years and concomitant corticotherapy in 4 of them. In 7 patients, the rupture was spontaneous and all required surgical management. A significantly higher frequency of smoking, concomitant corticotherapy and spontaneous ruptures were found in the group treated with fluoroquinolones.ConclusionsATR is an adverse event that can occur in patients over 60 years of age treated with fluoroquinolones, so an adequate risk-benefit assessment should be carried out in this population, especially in the presence of associated risk factors. 相似文献
92.
93.
Carolina B. Moraes Karen L. White Stéphanie Braillard Catherine Perez Junghyun Goo Luis Gaspar David M. Shackleford Anabela Cordeiro-da-Silva R. C. Andrew Thompson Lucio Freitas-Junior Susan A. Charman Eric Chatelain 《Antimicrobial agents and chemotherapy》2015,59(6):3645-3647
With the aim of improving the available drugs for the treatment of Chagas disease, individual enantiomers of nifurtimox were characterized. The results indicate that the enantiomers are equivalent in their in vitro activity against a panel of Trypanosoma cruzi strains; in vivo efficacy in a murine model of Chagas disease; in vitro toxicity and absorption, distribution, metabolism, and excretion characteristics; and in vivo pharmacokinetic properties. There is unlikely to be any therapeutic benefit of an individual nifurtimox enantiomer over the racemic mixture. 相似文献
94.
Luiz Francisco Rocha e Silva Karla Lagos Nogueira Ana Cristina da Silva Pinto Alejandro Miguel Katzin Rodrigo A. C. Sussmann Magno Perêa Muniz Valter Ferreira de Andrade Neto Francisco Célio Maia Chaves Julia Penna Coutinho Emerson Silva Lima Antoniana Ursine Krettli Wanderli Pedro Tadei Adrian Martin Pohlit 《Antimicrobial agents and chemotherapy》2015,59(6):3271-3280
4-Nerolidylcatechol (1) is an abundant antiplasmodial metabolite that is isolated from Piper peltatum roots. O-Acylation or O-alkylation of compound 1 provides derivatives exhibiting improved stability and significant in vitro antiplasmodial activity. The aim of this work was to study the in vitro inhibition of hemozoin formation, inhibition of isoprenoid biosynthesis in Plasmodium falciparum cultures, and in vivo antimalarial activity of several 4-nerolidylcatechol derivatives. 1,2-O,O-Diacetyl-4-nerolidylcatechol (2) inhibited in vitro hemozoin formation by up to 50%. In metabolic labeling studies using [1-(n)-3H]geranylgeranyl pyrophosphate, diester 2 significantly inhibited the biosynthesis of isoprenoid metabolites ubiquinone 8, menaquinone 4, and dolichol 12 in cultures of P. falciparum 3D7. Similarly, 2-O-benzyl-4-nerolidylcatechol (3) significantly inhibited the biosynthesis of dolichol 12. P. falciparum
in vitro protein synthesis was not affected by compounds 2 or 3. At oral doses of 50 mg per kg of body weight per day, compound 2 suppressed Plasmodium berghei NK65 in infected BALB/c mice by 44%. This in vivo result for derivative 2 represents marked improvement over that obtained previously for natural product 1. Compound 2 was not detected in mouse blood 1 h after oral ingestion or in mixtures with mouse blood/blood plasma in vitro. However, it was detected after in vitro contact with human blood or blood plasma. Derivatives of 4-nerolidylcatechol exhibit parasite-specific modes of action, such as inhibition of isoprenoid biosynthesis and inhibition of hemozoin formation, and they therefore merit further investigation for their antimalarial potential. 相似文献
95.
96.
97.
98.
Luis García de Guadiana-Romualdo Ignacio Español-Morales Pablo Cerezuela-Fuentes Luciano Consuegra-Sánchez Ana Hernando-Holgado Patricia Esteban-Torrella Enrique Jiménez-Santos Monserrat Viqueira-González África de Béjar-Almira María Dolores Albaladejo-Otón 《Supportive care in cancer》2015,23(7):2175-2182
99.
Escarlata Angullo-Martínez Enrique Carretero-Anibarro Ignacio Manuel Snchez Barrancos Xavier Cos Claramunt Domingo Orozco Beltrn Jos Luis Torres Baile Patxi Ezkurra Loiola en representacin del Grupo de Trabajo de Diabetes de la SemFyC en representacin del Grupo de Trabajo de Diabetes de la SemFyC 《Atencion primaria / Sociedad Espa?ola de Medicina de Familia y Comunitaria》2021,53(4)
Las circunstancias actuales provocadas por la COVID-19 nos obligan a los profesionales de atención primaria a idear nuevas formas de garantizar la atención sanitaria de nuestros pacientes con diabetes tipo 2 (DM2). Existen evidencias que respaldan la eficacia de la telemedicina en el control glucémico de los pacientes con DM2. Ante la rápida adaptación de la práctica clínica al uso de la telemedicina, el Grupo de Trabajo de Diabetes de la Sociedad Española de Medicina Familiar y Comunitaria (SemFyC) optó por elaborar un documento de consenso plasmado en un algoritmo de actuación/seguimiento telemático en la atención de los pacientes con DM2.Palabras clave: Telemedicina, Diabetes mellitus tipo 2, COVID-19 相似文献
100.